{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CYTK/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:53:06.730Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":103,"canonical_name":"CYTOKINETICS INC","cik":"0001061983","uei":null,"lei":null,"duns":null,"ticker":"CYTK"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":109},"count":100,"timeline":[{"ts":"2026-10-13","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-10-13","url_slug":"/sec/cik-0001061983/144/0001950047-26-010157","accession_number":"0001950047-26-010157","importance":30},{"ts":"2026-10-13","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-10-13","url_slug":"/sec/cik-0001061983/4/0001061983-26-000099","accession_number":"0001061983-26-000099","importance":30},{"ts":"2026-10-06","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-10-06","url_slug":"/sec/cik-0001061983/4/0001061983-26-000098","accession_number":"0001061983-26-000098","importance":30},{"ts":"2026-09-28","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-09-28","url_slug":"/sec/cik-0001061983/4/0001061983-26-000097","accession_number":"0001061983-26-000097","importance":30},{"ts":"2026-09-22","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-09-22","url_slug":"/sec/cik-0001061983/4/0001061983-26-000096","accession_number":"0001061983-26-000096","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-09-15","url_slug":"/sec/cik-0001061983/144/0001968582-26-000978","accession_number":"0001968582-26-000978","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-09-15","url_slug":"/sec/cik-0001061983/4/0001061983-26-000094","accession_number":"0001061983-26-000094","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-09-15","url_slug":"/sec/cik-0001061983/4/0001061983-26-000095","accession_number":"0001061983-26-000095","importance":30},{"ts":"2026-09-11","kind":"sec.form144","reporter":"ROBERT LANDRY","title":"Director","shares":2000,"usd_value":147240,"security_title":"Common","approx_sale_date":"2026-09-11","accession_number":"0001950047-26-009347","importance":40.029448},{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Landry Robert E","title":null,"shares":1000,"price_per_share":74.66,"usd_value":74660,"security_title":"Common Stock","importance":35.07466},{"ts":"2026-09-11","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-09-11","url_slug":"/sec/cik-0001061983/144/0001950047-26-009347","accession_number":"0001950047-26-009347","importance":30},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-09-11","url_slug":"/sec/cik-0001061983/4/0001061983-26-000093","accession_number":"0001061983-26-000093","importance":30},{"ts":"2026-09-08","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-09-08","url_slug":"/sec/cik-0001061983/4/0001061983-26-000092","accession_number":"0001061983-26-000092","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-09-01","url_slug":"/sec/cik-0001061983/144/0001950047-26-008948","accession_number":"0001950047-26-008948","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-09-01","url_slug":"/sec/cik-0001061983/4/0001061983-26-000091","accession_number":"0001061983-26-000091","importance":30},{"ts":"2026-08-31","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-08-31","url_slug":"/sec/cik-0001061983/4/0001061983-26-000089","accession_number":"0001061983-26-000089","importance":30},{"ts":"2026-08-31","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-08-31","url_slug":"/sec/cik-0001061983/4/0001061983-26-000090","accession_number":"0001061983-26-000090","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"8-K","title":"8-K — CYTOKINETICS INC — 2026-08-28","url_slug":"/sec/cik-0001061983/8-k/0001193125-26-372456","accession_number":"0001193125-26-372456","importance":35},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-08-18","url_slug":"/sec/cik-0001061983/4/0001061983-26-000088","accession_number":"0001061983-26-000088","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — CYTOKINETICS INC — 2026-08-13","url_slug":"/sec/cik-0001061983/8-k/0001193125-26-348060","accession_number":"0001193125-26-348060","importance":35},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CYTOKINETICS INC — 2026-08-13","url_slug":"/sec/cik-0001061983/schedule-13g-a/0000902219-26-000255","accession_number":"0000902219-26-000255","importance":30},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Blum Robert I","title":"President & CEO","shares":7500,"price_per_share":76.76,"usd_value":575700,"security_title":"Common Stock","importance":35.5757},{"ts":"2026-08-10","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-08-10","url_slug":"/sec/cik-0001061983/4/0001061983-26-000087","accession_number":"0001061983-26-000087","importance":30},{"ts":"2026-08-10","kind":"sec.insider.m","reporter":"Blum Robert I","title":"President & CEO","shares":7500,"price_per_share":10.6,"usd_value":79500,"security_title":"Common Stock","importance":15.0795},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CYTOKINETICS INC — 2026-08-06","url_slug":"/sec/cik-0001061983/10-q/0001193125-26-338217","accession_number":"0001193125-26-338217","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — CYTOKINETICS INC — 2026-08-06","url_slug":"/sec/cik-0001061983/8-k/0001193125-26-338021","accession_number":"0001193125-26-338021","importance":35},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Callos Andrew","title":"EVP, Chief Commercial Officer","shares":14000,"price_per_share":79.88,"usd_value":1118320,"security_title":"Common Stock","importance":36.11832},{"ts":"2026-07-30","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-07-30","url_slug":"/sec/cik-0001061983/144/0001950047-26-007436","accession_number":"0001950047-26-007436","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-30","url_slug":"/sec/cik-0001061983/4/0001061983-26-000086","accession_number":"0001061983-26-000086","importance":30},{"ts":"2026-07-30","kind":"sec.insider.m","reporter":"Callos Andrew","title":"EVP, Chief Commercial Officer","shares":14000,"price_per_share":23.26,"usd_value":325640,"security_title":"Common Stock","importance":15.32564},{"ts":"2026-07-27","kind":"sec.insider.s","reporter":"Blum Robert I","title":"President & CEO","shares":7500,"price_per_share":80.87,"usd_value":606525,"security_title":"Common Stock","importance":35.606525},{"ts":"2026-07-27","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-27","url_slug":"/sec/cik-0001061983/4/0001061983-26-000085","accession_number":"0001061983-26-000085","importance":30},{"ts":"2026-07-27","kind":"sec.insider.m","reporter":"Blum Robert I","title":"President & CEO","shares":7500,"price_per_share":10.6,"usd_value":79500,"security_title":"Common Stock","importance":15.0795},{"ts":"2026-07-23","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-23","url_slug":"/sec/cik-0001061983/4/0001061983-26-000084","accession_number":"0001061983-26-000084","importance":30},{"ts":"2026-07-21","kind":"sec.insider.s","reporter":"Malik Fady Ibraham","title":"EVP Research & Development","shares":3500,"price_per_share":80.59,"usd_value":282065,"security_title":"Common Stock","importance":35.282065},{"ts":"2026-07-21","kind":"sec.insider.m","reporter":"Malik Fady Ibraham","title":"EVP Research & Development","shares":3500,"price_per_share":7.8,"usd_value":27300,"security_title":"Common Stock","importance":15.0273},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-16","url_slug":"/sec/cik-0001061983/4/0001061983-26-000079","accession_number":"0001061983-26-000079","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-16","url_slug":"/sec/cik-0001061983/4/0001061983-26-000080","accession_number":"0001061983-26-000080","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-16","url_slug":"/sec/cik-0001061983/4/0001061983-26-000081","accession_number":"0001061983-26-000081","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-16","url_slug":"/sec/cik-0001061983/4/0001061983-26-000082","accession_number":"0001061983-26-000082","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-16","url_slug":"/sec/cik-0001061983/4/0001061983-26-000083","accession_number":"0001061983-26-000083","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-16","url_slug":"/sec/cik-0001061983/4/0001061983-26-000078","accession_number":"0001061983-26-000078","importance":30},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"HENDERSON JOHN T","title":null,"shares":272,"price_per_share":82.62,"usd_value":22473,"security_title":"Common Stock","importance":15.02247264},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"Harrington Robert Arthur","title":null,"shares":151,"price_per_share":82.62,"usd_value":12476,"security_title":"Common Stock","importance":15.01247562},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"Kaye Edward M. MD","title":null,"shares":151,"price_per_share":82.62,"usd_value":12476,"security_title":"Common Stock","importance":15.01247562},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"Daly James M","title":null,"shares":151,"price_per_share":82.62,"usd_value":12476,"security_title":"Common Stock","importance":15.01247562},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"WIERENGA WENDELL","title":null,"shares":75,"price_per_share":82.62,"usd_value":6197,"security_title":"Common Stock","importance":15.0061965},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"Wysenski Nancy","title":null,"shares":75,"price_per_share":82.62,"usd_value":6197,"security_title":"Common Stock","importance":15.0061965},{"ts":"2026-07-13","kind":"sec.insider.s","reporter":"Blum Robert I","title":"President & CEO","shares":7490,"price_per_share":82.02,"usd_value":614330,"security_title":"Common Stock","importance":35.6143298},{"ts":"2026-07-13","kind":"sec.insider.s","reporter":"Blum Robert I","title":"President & CEO","shares":10,"price_per_share":82.02,"usd_value":820,"security_title":"Common Stock","importance":35.0008202},{"ts":"2026-07-13","kind":"sec.insider.m","reporter":"Blum Robert I","title":"President & CEO","shares":7490,"price_per_share":10.6,"usd_value":79394,"security_title":"Common Stock","importance":15.079394},{"ts":"2026-07-08","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CYTOKINETICS INC — 2026-07-08","url_slug":"/sec/cik-0001061983/schedule-13g-a/0000315066-26-001467","accession_number":"0000315066-26-001467","importance":30},{"ts":"2026-07-07","kind":"sec.form144","reporter":"FADY MALIK","title":"Officer","shares":24500,"usd_value":2096465,"security_title":"Common","approx_sale_date":"2026-07-07","accession_number":"0001950047-26-006933","importance":40.419293},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Malik Fady Ibraham","title":"EVP Research & Development","shares":3500,"price_per_share":86.62,"usd_value":303170,"security_title":"Common Stock","importance":35.30317},{"ts":"2026-07-07","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-07-07","url_slug":"/sec/cik-0001061983/144/0001950047-26-006933","accession_number":"0001950047-26-006933","importance":30},{"ts":"2026-07-07","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-07","url_slug":"/sec/cik-0001061983/4/0001061983-26-000075","accession_number":"0001061983-26-000075","importance":30},{"ts":"2026-07-07","kind":"sec.insider.m","reporter":"Malik Fady Ibraham","title":"EVP Research & Development","shares":3500,"price_per_share":7.8,"usd_value":27300,"security_title":"Common Stock","importance":15.0273},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-02","url_slug":"/sec/cik-0001061983/4/0001061983-26-000072","accession_number":"0001061983-26-000072","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-02","url_slug":"/sec/cik-0001061983/4/0001061983-26-000073","accession_number":"0001061983-26-000073","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-07-02","url_slug":"/sec/cik-0001061983/4/0001061983-26-000074","accession_number":"0001061983-26-000074","importance":30},{"ts":"2026-07-01","kind":"sec.form144","reporter":"ROBERT BLUM","title":"Director, Officer","shares":52500,"usd_value":4472475,"security_title":"Common","approx_sale_date":"2026-07-01","accession_number":"0001950047-26-006752","importance":40.894495},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Callos Andrew","title":"EVP, Chief Commercial Officer","shares":15000,"price_per_share":85.8,"usd_value":1287000,"security_title":"Common Stock","importance":36.287},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Blum Robert I","title":"President & CEO","shares":7500,"price_per_share":84.92,"usd_value":636900,"security_title":"Common Stock","importance":35.6369},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":1112,"price_per_share":87.79,"usd_value":97622,"security_title":"Common Stock","importance":35.09762248},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-07-01","url_slug":"/sec/cik-0001061983/144/0001950047-26-006752","accession_number":"0001950047-26-006752","importance":30},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Callos Andrew","title":"EVP, Chief Commercial Officer","shares":15000,"price_per_share":23.26,"usd_value":348900,"security_title":"Common Stock","importance":15.3489},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":1112,"price_per_share":48.51,"usd_value":53943,"security_title":"Common Stock","importance":15.05394312},{"ts":"2026-06-29","kind":"sec.form144","reporter":"Sung Lee","title":"Officer","shares":9503,"usd_value":781052,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001950047-26-006619","importance":40.156210314},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":3134,"price_per_share":85,"usd_value":266390,"security_title":"Common Stock","importance":35.26639},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-06-29","url_slug":"/sec/cik-0001061983/144/0001950047-26-006619","accession_number":"0001950047-26-006619","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-06-29","url_slug":"/sec/cik-0001061983/4/0001061983-26-000070","accession_number":"0001061983-26-000070","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-06-29","url_slug":"/sec/cik-0001061983/4/0001061983-26-000071","accession_number":"0001061983-26-000071","importance":30},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":1113,"price_per_share":48.51,"usd_value":53992,"security_title":"Common Stock","importance":15.05399163},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":823,"price_per_share":44.36,"usd_value":36508,"security_title":"Common Stock","importance":15.03650828},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":822,"price_per_share":44.36,"usd_value":36464,"security_title":"Common Stock","importance":15.03646392},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":188,"price_per_share":44.36,"usd_value":8340,"security_title":"Common Stock","importance":15.00833968},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":188,"price_per_share":44.36,"usd_value":8340,"security_title":"Common Stock","importance":15.00833968},{"ts":"2026-06-26","kind":"sec.form144","reporter":"Sung Lee","title":"Officer","shares":6695,"usd_value":540956,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001950047-26-006540","importance":40.1081912},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-06-26","url_slug":"/sec/cik-0001061983/144/0001950047-26-006540","accession_number":"0001950047-26-006540","importance":30},{"ts":"2026-06-24","kind":"sec.form144","reporter":"Sung Lee","title":"Officer","shares":38730,"usd_value":3098787,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001950047-26-006466","importance":40.61975746},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":38730,"price_per_share":82.3,"usd_value":3187479,"security_title":"Common Stock","importance":38.187479},{"ts":"2026-06-24","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-06-24","url_slug":"/sec/cik-0001061983/144/0001950047-26-006466","accession_number":"0001950047-26-006466","importance":30},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":23370,"price_per_share":48.51,"usd_value":1133679,"security_title":"Common Stock","importance":16.1336787},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":9307,"price_per_share":44.36,"usd_value":412859,"security_title":"Common Stock","importance":15.41285852},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":2817,"price_per_share":44.36,"usd_value":124962,"security_title":"Common Stock","importance":15.12496212},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":1113,"price_per_share":48.51,"usd_value":53992,"security_title":"Common Stock","importance":15.05399163},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":1113,"price_per_share":48.51,"usd_value":53992,"security_title":"Common Stock","importance":15.05399163},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":822,"price_per_share":44.36,"usd_value":36464,"security_title":"Common Stock","importance":15.03646392},{"ts":"2026-06-24","kind":"sec.insider.m","reporter":"Lee Sung","title":"EVP, Chief Financial Officer","shares":188,"price_per_share":44.36,"usd_value":8340,"security_title":"Common Stock","importance":15.00833968},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Blum Robert I","title":"President & CEO","shares":7500,"price_per_share":70.46,"usd_value":528450,"security_title":"Common Stock","importance":35.52845},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-06-15","url_slug":"/sec/cik-0001061983/4/0001061983-26-000068","accession_number":"0001061983-26-000068","importance":30},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"Malik Fady Ibraham","title":"EVP Research & Development","shares":3500,"price_per_share":67.98,"usd_value":237930,"security_title":"Common Stock","importance":35.23793},{"ts":"2026-06-09","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-06-09","url_slug":"/sec/cik-0001061983/4/0001061983-26-000067","accession_number":"0001061983-26-000067","importance":30},{"ts":"2026-06-09","kind":"sec.insider.m","reporter":"Malik Fady Ibraham","title":"EVP Research & Development","shares":3500,"price_per_share":7.8,"usd_value":27300,"security_title":"Common Stock","importance":15.0273},{"ts":"2026-06-01","kind":"sec.form144","reporter":"EDWARD KAYE","title":"Director","shares":2933,"usd_value":225137,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001950047-26-005367","importance":40.045027416},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Callos Andrew","title":"EVP, Chief Commercial Officer","shares":15000,"price_per_share":74.08,"usd_value":1111200,"security_title":"Common Stock","importance":36.1112},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"PARSHALL B LYNNE","title":null,"shares":5000,"price_per_share":74.08,"usd_value":370400,"security_title":"Common Stock","importance":35.3704},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Kaye Edward M. MD","title":null,"shares":2933,"price_per_share":76.09,"usd_value":223172,"security_title":"Common Stock","importance":35.22317197},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — CYTOKINETICS INC — 2026-06-01","url_slug":"/sec/cik-0001061983/144/0001950047-26-005367","accession_number":"0001950047-26-005367","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — CYTOKINETICS INC — 2026-06-01","url_slug":"/sec/cik-0001061983/4/0001061983-26-000064","accession_number":"0001061983-26-000064","importance":30}]}